Cite

1037. Qualitative Findings from a Hybrid III Implementation-Effectiveness Study to Explore Perspectives of Health-care Staff on Early Implementation of Cabotegravir and Rilpivirine Long Acting (CAB+RPV LA) Injectable HIV treatment in the US (CUSTOMIZE)

MLA

Colleen A. McHorney, et al. “1037. Qualitative Findings from a Hybrid III Implementation-Effectiveness Study to Explore Perspectives of Health-Care Staff on Early Implementation of Cabotegravir and Rilpivirine Long Acting (CAB+RPV LA) Injectable HIV Treatment in the US (CUSTOMIZE).” Open Forum Infectious Diseases, vol. 7, no. Suppl 1, Dec. 2020, p. S549. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....6dd1362e689e7f37d98d476144ecfaa9&authtype=sso&custid=ns315887.



APA

Colleen A. McHorney, Paul Wannamaker, William V. Williams, Larissa Stassek, Carolyn Selenski, Cindy Garris, Leandro Mena, Gary I Sinclair, Maggie Czarnogorski, Michael Wohlfeiler, Ronald D’Amico, & David Margolis. (2020). 1037. Qualitative Findings from a Hybrid III Implementation-Effectiveness Study to Explore Perspectives of Health-care Staff on Early Implementation of Cabotegravir and Rilpivirine Long Acting (CAB+RPV LA) Injectable HIV treatment in the US (CUSTOMIZE). Open Forum Infectious Diseases, 7(Suppl 1), S549.



Chicago

Colleen A. McHorney, Paul Wannamaker, William V. Williams, Larissa Stassek, Carolyn Selenski, Cindy Garris, Leandro Mena, et al. 2020. “1037. Qualitative Findings from a Hybrid III Implementation-Effectiveness Study to Explore Perspectives of Health-Care Staff on Early Implementation of Cabotegravir and Rilpivirine Long Acting (CAB+RPV LA) Injectable HIV Treatment in the US (CUSTOMIZE).” Open Forum Infectious Diseases 7 (Suppl 1): S549. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....6dd1362e689e7f37d98d476144ecfaa9&authtype=sso&custid=ns315887.